Emergence of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for human immunodeficiency virus infection

被引：0

作者：

Diri, E

Lipsky, PE

Berggren, RE

机构：

[1] Univ Texas, SW Med Ctr, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA

[2] Univ Texas, SW Med Ctr, Dept Internal Med, Div Rheumat Dis, Dallas, TX 75390 USA

[3] NIAMSD, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF RHEUMATOLOGY | 2000年 / 27卷 / 11期

关键词：

autoimmunity; lupus; human immunodeficiency virus; immune reconstitution disease; antiretroviral therapy;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Systemic lupus erythematosus (SLE) may be influenced by human immunodeficiency virus type-1 (HIV) infection. It has been suggested that the immunosuppression resulting from HIV infection can prevent the emergence of SLE. There appear to be fewer cases of SLE in the HIV infected population than would be predicted, based on the overall incidence of SLE. We describe a person with HIV infection who developed SLE after the initiation of highly active antiretroviral therapy.

引用

页码：2711 / 2714

页数：4

共 50 条

[41] Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection
Samaras, Katherine
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 238 - 245
[42] Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy
Weinberg, A
Pott, GB
[J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) : 821 - 825
[43] Human Immunodeficiency Virus Infection: Does Highly Active Antiretroviral Therapy Influence Ear Nose Throat Manifestations?
Dosemane D.
Kumar V.
Madi D.
Kanthila J.
[J]. Indian Journal of Otolaryngology and Head & Neck Surgery, 2018, 70 (4) : 555 - 558
[44] Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection
Childers, Meredith E.
Woods, Steven Paul
Letendre, Scott
McCutchan, J. Allen
Rosario, Debralee
Grant, Igor
Mindt, Monica Rivera
Ellis, Ronald J.
[J]. JOURNAL OF NEUROVIROLOGY, 2008, 14 (06) : 550 - 557
[45] Cognitive functioning during highly active antiretroviral therapy interruption in human immunodeficiency virus type 1 infection
Meredith E. Childers
Steven Paul Woods
Scott Letendre
J. Allen McCutchan
Debralee Rosario
Igor Grant
Monica Rivera Mindt
Ronald J. Ellis
[J]. Journal of NeuroVirology, 2008, 14 : 550 - 557
[46] Acanthosis nigricans as an adverse effect of highly active antiretroviral therapy in an adolescent girl with human immunodeficiency virus infection
Mur, A
Seidel, V
López-Vílchez, MA
Bonet, M
Gilaberte, M
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (08) : 742 - 743
[47] Human immunodeficiency virus infection and systemic lupus erythernatosus
Palacios, R
Santos, J
[J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2004, 15 (04) : 277 - 278
[48] Impact of highly active antiretroviral therapy on survival from progressive multifocal leukoencephalopathy in human immunodeficiency virus infection
Clifford, DB
[J]. NEUROLOGY, 1998, 50 (04) : A249 - A249
[49] Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy
Calza, L
Manfredi, R
Colangeli, V
D'Antuono, A
Passarini, B
Chiodo, F
[J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (05) : 356 - 359
[50] Immune restoration in human immunodeficiency virus and hepatitis C virus coinfected patients after highly active antiretroviral therapy
Antonello, Vicente Sperb
Appel-da-Silva, Marcelo Campos
Kliemann, Dimas Alexandre
Santos, Breno Riegel
Tovo, Cristiane Valle
[J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (05): : 551 - 554

← 1 2 3 4 5 →